Table of Contents
Guest Editorials
| EGFR tyrosine kinase inhibitors in lung cancer: make no assumptions | PDF HTML |
| B. Melosky | 8 |
| A model for breast cancer risk based on stem-cell theory | PDF HTML |
| S. A. Narod | 9-11 |
| Cancer control: life and death in an unequal world | PDF HTML |
| S. B. Sutcliffe | 12-15 |
| A call for action in survivorship research and care | PDF HTML |
| R. Doll, A. Kazanjian, K. Smillie, A. Ward, M. Chasen | 16-20 |
Letter to the Editor
| Second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer | PDF HTML |
| V. Hirsh | 21-22 |
E-Manuscript Article Summaries
| E-manuscript Article Summaries | PDF HTML |
| 23-26 |
Cancer Biomarkers
| Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer | PDF HTML |
| R. Moro, J. Gulyaeva–Tcherkassova, P. Stieber | e1-8 |
Knowledge Translation
| Challenges in knowledge translation: the early years of Cancer Care Ontario’s Program in Evidence-Based Care | PDF HTML |
| G. P. Browman | 27-35 |
Medical Oncology
| Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis | PDF HTML |
| K. Alsaleh, C. Quinton, P. M. Ellis | e9-15 |
Oncologic Pathology
| Fine-needle aspiration biopsy versus core-needle biopsy in diagnosing lung cancer: a systematic review | PDF HTML |
| X. Yao, M. M. Gomes, M. S. Tsao, C. J. Allen, W. Geddie, H. Sekhon | e16-27 |
Updates and Developments in Oncology
| Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis | PDF HTML |
| A. Bagnato, L. Rosanò | 36-38 |
| Major histocompatibility complex class i and tumour immuno-evasion: how to fool T cells and natural killer cells at one time | PDF HTML |
| D. Fruci, M. Benevolo, L. Cifaldi, S. Lorenzi, E. Lo Monaco, E. Tremante, P. Giacomini | 39-41 |
| Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours | PDF HTML |
| A. Frost, K. Mross, S. Steinbild, S. Hedbom, C. Unger, R. Kaiser, D. Trommeshauser, G. Munzert | e28-35 |
Case Report
| Response to second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer: make no assumptions | PDF HTML |
| I. Karam, B. Melosky | 42-46 |
| Medullary thyroid cancer and pseudocirrhosis: case report and literature review | PDF HTML |
| B. L. Harry, M.L. Smith, J.R. Burton Jr, A. Dasari, S.G. Eckhardt, J.R. Diamond | e36-41 |
Corrigenda
| Corrigendum: Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba | PDF HTML |
| e42 |
Copyright © 2012 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)